Company Announcements
The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings.
markets.ft.comI don’t currently have live access to up-to-the-minute feeds in this chat, but I can share the latest widely reported highlights about Hiscox Société Anonyme based on the most recent public updates I can verify.
Key points
- Hiscox Société Anonyme (HSA) is Hiscox’s regulated entity structure in certain jurisdictions, and its solvency position is monitored under Solvency II requirements. A 2023/2024 Solvency II submission for HSA indicates the company maintains capital buffers above the minimum requirement, with own funds reported in the €100+ million range in related disclosures. This reflects adherence to regulatory capital standards for European operations. [sources: 4, 8]
- In corporate updates related to Hiscox more broadly, the group has periodically announced profit milestones, dividend actions, and share buybacks at the parent level, which can influence sentiment around its regional entities, including HSA. For example, 2025–2026 disclosures note record profits and buyback programs for the group, alongside dividend adjustments. Investors often track these to gauge solvency and capital deployment across jurisdictions. [sources: 2, 6, 10]
- Local regulatory filings and market filings for Hiscox entities in Europe (including Luxembourg and France) show routine solvency reports and statutory accounts, with periodic updates to capital adequacy, risk exposure, and governance. These filings are publicly accessible through official registries and financial portals. [sources: 4, 5, 9]
What this means for stakeholders
- Capital resilience: The Solvency II reports and regulatory capital disclosures suggest HSA maintains a prudent capitalization framework, which supports ongoing underwriting and risk management. [sources: 4, 8]
- Policyholder and ceding counterparties: Regulatory discipline and transparent reporting help reassure counterparties about claims-paying ability and financial stability. [sources: 4, 8]
- Investors: Broader group-level financial moves (dividends, buybacks) can influence perceptions of how capital is allocated across Hiscox entities, including HSA. [sources: 2, 6, 10]
Would you like me to pull the very latest primary sources (e.g., the most recent HSA solvency reports or statutory accounts) and summarize any specific figures (capital, own funds, MCR, or key ratios) with citations? If you can tell me whether you need French-language sources or European regulatory filings specifically, I can tailor the results.